Three (23%) of the 13 PDAC patients with a personal history of breast or ovarian cancer had deleterious mutations, two BRCA2 mutations and one ATM mutation, the latter of which was described in the previous section (NCCH-16) (Table 4). Here, ATM is linked to ovarian cancer.